vs

Side-by-side financial comparison of TECOGEN INC. (TGEN) and UNITED GUARDIAN INC (UG). Click either name above to swap in a different company.

TECOGEN INC. is the larger business by last-quarter revenue ($5.3M vs $3.0M, roughly 1.8× UNITED GUARDIAN INC). On growth, UNITED GUARDIAN INC posted the faster year-over-year revenue change (19.6% vs -12.5%). UNITED GUARDIAN INC produced more free cash flow last quarter ($308.0K vs $-2.6M). Over the past eight quarters, UNITED GUARDIAN INC's revenue compounded faster (-4.6% CAGR vs -7.3%).

The Guardian Life Insurance Company of America is one of the largest mutual life insurance companies in the world. Based in Manhattan, it has approximately 8,000 employees in the United States, and a network of over 3,000 financial representatives in more than 70 agencies nationwide. As of 2018, it ranks 239th on the Fortune 500 list of largest American corporations by revenue. In 2015, Guardian achieved the highest earnings in its 155-year history with $7.3 billion in capital and $1.5 billio...

TGEN vs UG — Head-to-Head

Bigger by revenue
TGEN
TGEN
1.8× larger
TGEN
$5.3M
$3.0M
UG
Growing faster (revenue YoY)
UG
UG
+32.1% gap
UG
19.6%
-12.5%
TGEN
More free cash flow
UG
UG
$2.9M more FCF
UG
$308.0K
$-2.6M
TGEN
Faster 2-yr revenue CAGR
UG
UG
Annualised
UG
-4.6%
-7.3%
TGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TGEN
TGEN
UG
UG
Revenue
$5.3M
$3.0M
Net Profit
$-4.0M
Gross Margin
36.8%
45.0%
Operating Margin
-77.8%
24.4%
Net Margin
-75.1%
Revenue YoY
-12.5%
19.6%
Net Profit YoY
-236.7%
EPS (diluted)
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TGEN
TGEN
UG
UG
Q4 25
$5.3M
$3.0M
Q3 25
$7.2M
$2.3M
Q2 25
$7.3M
$2.8M
Q1 25
$7.3M
$2.5M
Q4 24
$6.1M
$2.5M
Q3 24
$5.6M
$3.1M
Q2 24
$4.7M
$3.4M
Q1 24
$6.2M
$3.3M
Net Profit
TGEN
TGEN
UG
UG
Q4 25
$-4.0M
Q3 25
$-2.1M
$268.4K
Q2 25
$-1.5M
$626.8K
Q1 25
$-659.9K
$560.9K
Q4 24
$-1.2M
Q3 24
$-930.4K
$865.5K
Q2 24
$-1.5M
$956.2K
Q1 24
$-1.1M
$925.4K
Gross Margin
TGEN
TGEN
UG
UG
Q4 25
36.8%
45.0%
Q3 25
30.4%
42.1%
Q2 25
33.8%
52.8%
Q1 25
44.3%
54.7%
Q4 24
45.0%
51.7%
Q3 24
44.1%
54.0%
Q2 24
44.0%
54.0%
Q1 24
41.6%
52.2%
Operating Margin
TGEN
TGEN
UG
UG
Q4 25
-77.8%
24.4%
Q3 25
-29.2%
9.5%
Q2 25
-19.4%
24.5%
Q1 25
-8.2%
24.6%
Q4 24
-18.7%
22.5%
Q3 24
-15.5%
31.0%
Q2 24
-31.2%
32.9%
Q1 24
-17.0%
31.5%
Net Margin
TGEN
TGEN
UG
UG
Q4 25
-75.1%
Q3 25
-29.7%
11.9%
Q2 25
-20.1%
22.1%
Q1 25
-9.1%
22.6%
Q4 24
-19.5%
Q3 24
-16.5%
28.3%
Q2 24
-32.5%
28.2%
Q1 24
-17.9%
28.4%
EPS (diluted)
TGEN
TGEN
UG
UG
Q4 25
$-0.14
Q3 25
$-0.07
Q2 25
$-0.06
Q1 25
$-0.03
Q4 24
$-0.05
Q3 24
$-0.04
Q2 24
$-0.06
Q1 24
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TGEN
TGEN
UG
UG
Cash + ST InvestmentsLiquidity on hand
$12.4M
$8.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$21.6M
$11.2M
Total Assets
$37.0M
$13.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TGEN
TGEN
UG
UG
Q4 25
$12.4M
$8.6M
Q3 25
$15.3M
$8.3M
Q2 25
$1.6M
$8.4M
Q1 25
$4.1M
$8.1M
Q4 24
$5.4M
$9.4M
Q3 24
$1.3M
$9.5M
Q2 24
$841.9K
$9.9M
Q1 24
$1.5M
$8.6M
Stockholders' Equity
TGEN
TGEN
UG
UG
Q4 25
$21.6M
$11.2M
Q3 25
$25.5M
$10.6M
Q2 25
$9.1M
$11.5M
Q1 25
$9.6M
$10.8M
Q4 24
$10.2M
$11.9M
Q3 24
$11.3M
$11.4M
Q2 24
$12.2M
$12.1M
Q1 24
$13.7M
$11.2M
Total Assets
TGEN
TGEN
UG
UG
Q4 25
$37.0M
$13.1M
Q3 25
$41.5M
$12.2M
Q2 25
$28.4M
$13.4M
Q1 25
$29.7M
$12.8M
Q4 24
$31.1M
$13.8M
Q3 24
$27.5M
$13.3M
Q2 24
$27.2M
$13.8M
Q1 24
$28.5M
$13.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TGEN
TGEN
UG
UG
Operating Cash FlowLast quarter
$-2.6M
$330.5K
Free Cash FlowOCF − Capex
$-2.6M
$308.0K
FCF MarginFCF / Revenue
-49.3%
10.4%
Capex IntensityCapex / Revenue
0.9%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-10.3M
$1.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TGEN
TGEN
UG
UG
Q4 25
$-2.6M
$330.5K
Q3 25
$-3.6M
$1.0M
Q2 25
$-2.6M
$303.2K
Q1 25
$-1.2M
$322.1K
Q4 24
$4.2M
$269.3K
Q3 24
$-207.3K
$1.2M
Q2 24
$-157.9K
$1.3M
Q1 24
$248.2K
$644.1K
Free Cash Flow
TGEN
TGEN
UG
UG
Q4 25
$-2.6M
$308.0K
Q3 25
$-3.6M
$995.8K
Q2 25
$-2.7M
$285.6K
Q1 25
$-1.3M
$318.5K
Q4 24
$4.0M
$-45.9K
Q3 24
$-489.6K
$1.2M
Q2 24
$-609.6K
$1.3M
Q1 24
$143.3K
$622.2K
FCF Margin
TGEN
TGEN
UG
UG
Q4 25
-49.3%
10.4%
Q3 25
-50.6%
44.0%
Q2 25
-37.7%
10.1%
Q1 25
-17.9%
12.8%
Q4 24
66.6%
-1.9%
Q3 24
-8.7%
39.2%
Q2 24
-12.9%
37.1%
Q1 24
2.3%
19.1%
Capex Intensity
TGEN
TGEN
UG
UG
Q4 25
0.9%
0.8%
Q3 25
1.0%
0.7%
Q2 25
2.0%
0.6%
Q1 25
1.8%
0.1%
Q4 24
2.1%
12.7%
Q3 24
5.0%
1.0%
Q2 24
9.6%
1.9%
Q1 24
1.7%
0.7%
Cash Conversion
TGEN
TGEN
UG
UG
Q4 25
Q3 25
3.77×
Q2 25
0.48×
Q1 25
0.57×
Q4 24
Q3 24
1.42×
Q2 24
1.38×
Q1 24
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TGEN
TGEN

Installation Services$4.5M84%
Products Segment$460.5K9%
Other$394.7K7%

UG
UG

Pharmaceuticals$1.6M53%
Other$1.4M47%

Related Comparisons